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INTRODUCTION
Radiation therapy (RT) in general requires a treat-
ment period of 5 to 7 weeks. Tumor shrinkage in
response to RT and weight loss due to radiation-
induced mucositis may impact on the dose distri-
bution in both target and organ at risk in patients
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Abstract : The treatment period over which radiation therapy is administered extends
over several weeks. Since tumor shrinkage in response to radiation therapy and weight
loss due to radiation-induced mucositis may impact on the dose distribution in both tar-
get and organ at risk in patients with head and neck cancer, the anatomical changes of
tumor and neck volumes during this period should be taken into consideration. We in-
vestigated the anatomical changes that occurred in the target and normal structure of
the neck during radiation therapy for pharyngeal cancer, and evaluated the necessity of
an adaptive strategy. Ten patients with pharyngeal cancer who underwent radical
chemoradiation therapy using 3-dimensional conformal radiation therapy RT (66-70 Gy
in 33-35 fractions) between April 2009 and September 2010 were enrolled in the study.
Patients underwent CT scans every week during their course of treatment. We analyzed
the CT data in the radiation treatment planning system and measured changes of tumor,
organ at risk, and neck volume. Gross tumor volume (GTV) was rapidly reduced by 28%
of the original volume on average in the first 3 weeks. The right and left submandibular
glands volume decreased to 70% and 63% of their initial volumes on average, respec-
tively. The volume of the neck in the radiation fields decreased to 89% of its initial vol-
ume on average by the sixth week mainly caused by body weight loss due to acute radia-
tion morbidity. Considerable anatomical change in the radiation filed that will affect
dose distribution of the target and organ at risk was observed during radiation therapy
for head and neck cancer. J. Med. Invest. 60 : 46-51, February, 2013
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with head and neck cancer. However, anatomical
changes of tumor and normal tissues in the treat-
ment field during the course of treatment are not
considered. Anatomical changes during the treat-
ment period may affect the therapeutic outcome of
high precision external beam therapies such as in-
tensity modulated radiation therapy (IMRT). IMRT
enables conformal dose distribution to the target,
and more highly precision is required in positioning
of the target than conventional 3-dimensional con-
formal RT. Anatomical changes during the course
of treatment can cause radiation overdose to the
organ at risk or lack of dose to the target. In some
studies (1-3), influence of anatomical changes that
occurred during the course of image guided RT
(IGRT) on dose distribution have been investigated
using kilovoltage CT (KVCT) and megavoltage CT
(MVCT). The study (4) that evaluated changes of
gross tumor volume (GTV) occurring during RT
for non-small-cell lung cancer concluded that ad-
ditional radiation treatment planning is necessary
when the gross tumor volume (GTV) had decreased
by more than 30%. In the studies (5, 6) in which
anatomical changes during RT for head and neck
cancer were investigated, the possibility that ana-
tomical changes could affect the dose distribution
was underlined. In the present study, we investi-
gated the necessity of an adaptive strategy for ra-
diation therapy of head and neck cancer, by evalu-
ating anatomical changes of the tumor and normal
structures in the radiation fields.
MATERIALS AND METHODS
Patient characteristics
This prospective study was approved by our In-
stitutional Review Board, and informed consent
was waived. Ten patients who underwent radical
chemoradiation therapy (CRT) for pharyngeal can-
cer between April 2009 and September 2010 were
enrolled in this study (Table 1).
Chemoradiation therapy
Radiation treatment planning was performed us-
ing a 3-dimensional radiation treatment planning
system (RTPS, Xio ver. 4.5.0, Computerized Medi-
cal Systems, Maryland Heights, MO, USA) at the
beginning of CRT with a prescription dose of 66-
70 Gy/33-35 fractions. All patients underwent two
courses of concurrent chemotherapy consisting of
5-fluorouracil+cisplatin.
Volume measurement of target and organ at risk
All contours of the target and organ at risk were
delineated on the computed tomography (CT)-mag-
netic resonance imaging (MRI) fusion images by
the same radiation oncologist (H. I.). The CT scan
was performed using an Asteion Super 4 Edition
multislice (Toshiba Medical Systems, Tochigi, Ja-
pan), and MR images were obtained using a Signa
Excite HD 1.5T (GE Yokogawa Medical Systems,
Tokyo, Japan). All patients underwent a CT scan
every week during the treatment course at the
same fixed position as the position used for RT.
The position was maintained using an immobilizing
mask made of thermoplastic plastics. The whole
neck between the base of the skull and the supracla-
vicular region was scanned at a 3 mm slice thick-
ness. Target and organ at risk delineated in this
study are listed in Table 2.
During the course of the treatment period, the
isocenter remained the same. The volume of the
target and critical organ were measured on every
CT scan, and body weight, serum protein, and acute
radiation toxicity (common toxicity criteria version
Table 1. Patient characteristics
Pt. No Gender Age cTNM Stage Disease Hisotology
1 M 62 T3N2bM0 IVA oropharyngeal cancer SCC
2 M 78 T4aN1M0 IVA oropharyngeal cancer SCC
3 M 52 T3N2bM0 IVA oropharyngeal cancer SCC
4 M 68 T4N2cM0 IVA oropharyngeal cancer SCC
5 M 62 T4N2M0 IVA epipharyngeal cancer SCC
6 M 67 T1N2M0 III epipharyngeal cancer SCC
7 F 61 T2N2cM0 IVA oropharyngeal cancer SCC
8 M 54 T4N2bM0 IVB oropharyngeal cancer SCC
9 M 67 T2N2bM0 IVA oropharyngeal cancer SCC
10 M 64 T3N2cM1 IVA hypopharyngeal cancer SCC
SCC, squamous cell cancer
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3.0) was evaluated every week during treatment.
The volume of the target and organ at risk was
calculated automatically by delineating the contours
on RTPS.
Estimated dose changes of the spinal cord caused
by anatomical changes in IMRT
Fig. 1 is showing a dose distribution of postu-
lated IMRT planning. Estimated change of maxi-
mum dose of the spinal cord if IMRT was applied
to the same situation of anatomical changes derived
from the data of the present study was calculated.
Upper limit of dose of spinal cord was set at 40 Gy
in the treatment planning of IMRT.
Statistical analysis
Analysis of variance was performed using Excell
ver. 2007. (Microsoft Corporation, Tokyo, Japan)
Two-factor ANOVA was used to evaluate a statisti-
cal significance in reduction of GTV, submandibu-
lar gland, neck volume, body weight loss, and se-
rum protein. Turkeykramer method of post-hoc-
test was used for the comparison between the
groups every week. Test of coefficient of correlation
of Pearson was used to evaluate the correlation be-
tween body weight loss and cervical volume reduc-
tion.
RESULTS
Changes of GTV and the submandibular gland
of a case who had oropharyngeal cancer are shown
in Fig. 1. Changes of GTV and volume of the sub-
mandibular glands are shown in Figs 2, 3 and 4. A
marked reduction of GTV by 28% of the initial vol-
ume was seen by the third week during RT (P
0.01). By the sixth week, an average reduction of
volume of 30 and 27% was observed in the right and
left submandibular gland, respectively (P0.01).
Not only GTV but also the volume of the submandi-
bular glands and the cervical volume were reduced
Table 2. Delineation of targets and organ at risk
GTV Visible tumor on imaging
CTV1 GTV+5 mm isotropic margin
PTV1 CTV+3 mm isotropic margin
CTV2 Prophylactic lymph node area (7, 8).
PTV2 CTV2+3 mm isotropic margin
Normal tissue
(submandibular glands, spinal cord)
Spinal cord was identified using an automatic
outline drawing function.
Dens The origin of the coordinate axes was set at thecenter of the dens in all radiotherapy planning.
Cervical volume
We defined it as the volume of the neck between
the range of3.9 cm from an isocenter.
Outer contour of the neck was identified using
an automatic outline drawing function.
GTV, gross tumor volume ; CTV, clinical target volume ; PTV, planning target volume
Fig. 1. Axial images of computed tomography (CT) of a patient
with oropharyngeal cancer, Gross tumor volume and spinal cord
were delineated on CT.
(a) : Planning CT at initiation of radiation therapy
(b) : Four weeks after initiation of radiation therapy
(c) : Dose distribution chart of IMRT on initial treatment plan-
ning CT
(d) : Dose distribution chart of IMRT projected on CT iamge at
4 weeks after initiation of radiation therapy
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by 4 weeks after the beginning of CRT (P0.01).
Changes of body weight, volume of the neck and
serum protein are shown in Fig. 5, 6, and 7. CTC
Grade of radiation mucositis increased up to 2 or 3
during RT in all patients.
There was body weight loss of 7%, neck volume
reduction of 11%, and serum protein reduction of
12% on average during CRT, caused by eating dis-
order due to radiation mucositis. There was statis-
tically significant correlation between the body
weight loss and the cervical volume reduction (r=
0.59, P0.07). (Fig. 8)
When IMRT plan was applied to the same situ-
ation of anatomical changes derived from the pre-
sent study, cumulated dose of spinal cord exceeded
upper dose limit of 40 Gy defined at the initial treat-
ment planning in 2 patients (patient No2 and 10).
(Fig. 9)
Fig. 2. Weekly changes of GTV, columns and bars mean av-
eragesSE, *p0.05 vs. 0W, **p0.01 vs. 0W
Fig. 3. Weekly changes of volume of right submandibular
gland, columns and bars mean averagesSE, *p0.05 vs. 0W,
**p0.01 vs. 0W
Fig. 6. Weekly changes of cervical volume, columns and bars
mean averagesSE, *p0.05 vs. 0W, **p0.01 vs. 0W
Fig. 7. Weekly changes of Serum protein, columns and bars
mean averagesSE, *p0.05 vs. 0W, **p0.01 vs. 0W
Fig. 4. Weekly changes of volume of left submandibular gland,
columns and bars mean averagesSE, *p0.05 vs. 0W, **p
0.01 vs. 0W
Fig. 5. Weekly changes of body weight, columns and bars
mean averagesSE, *p0.05 vs. 0W, **p0.01 vs. 0W
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DISCUSSION
Considerable anatomical changes occurred dur-
ing CRT, especially in tumor volume as a response
of CRT within 3 weeks after initiation of CRT. Sig-
nificant scaling down of normal soft tissue surround-
ing the tumor and organ at risk caused by hypoali-
mentation as a consequence of acute radiation mor-
bidity and volume reduction of salivary glands prob-
ably caused by functional deterioration due to CRT
were also observed. IMRT simulation using these
data showed that anatomical changes during CRT
became a risk to increase radiation dose of organ
at risk over the upper limit of dose constraint de-
fined at treatment planning.
There are a number of previous studies (9, 10)
concerning anatomical changes of organ at risk dur-
ing the course of RT. They reported that the parotid
volume decreased during the course of RT period.
Barker J (5) repoted that the mean dose of radia-
tion delivered to the parotid glands had increased
by more than 10% during RT (11). Lee et al. (12)
reported that the location of the parotid glands in
the radiation field shifted to the center, while this
change in location was not seen in most of the
parotid glands which were not irradiated. These
authors found that the parotid volume decreased
and that consequently the mean dose of radiation
delivered to the parotid glands was increased. In
the present study, we did not evaluate anatomical
changes of the parotid glands because reproduci-
bility in the contouring of parotid glands could not
be maintained due to the complexity of its shape.
Some authors reported that the submandibular
glands in the radiation field shifted to a central lo-
cation, and to a higher region of the oral cavity
(12), while there was no change in the position of
the unirradiated submandibular glands.
Maintenance of adequate nutritional supplemen-
tation during CRT seems to be an important coun-
termeasure that can reduce anatomical changes due
to body weight loss. Good nutritional status will also
contribute to recovery from acute radiation mor-
bidity. Nutritional supplementation via a temporal
gastrostoma is one way of maintaining the patient’s
nutritional status. However, anatomical changes
caused by tumor shrinkage and volume reduction
of the salivary gland are an unavoidable event in
CRT for head and neck cancer.
IMRT enables conformal dose distribution around
the target, and more precision is required than con-
ventional 3-dimensional conformal RT. Anatomical
changes that occur during the course of treatment
may cause lack of dose to the target and overdose
to the organ at risk. The introduction of an adap-
tive strategy in highly precise external beam RT
for head and neck cancer can reduce the influence
of anatomical changes during the course of CRT.
Barke et al. (5) reported that the therapeutic ratio
can be improved by performing adaptive planning
in RT for head and neck cancer. An appropriate
schedule for an adaptive radiation treatment plan has
not yet been established. In practice, we perform a
re-treatment planning of IMRT when a total dose
of 30 Gy is delivered, because GTV rapidly reduces
within first 3 weeks. Re-planning based on CT data
for every individual irradiation during a course of
fractionated treatment is ideal. However, It is impos-
sible to perform re-planning according to the daily
anatomical changes. Development of treatment plan-
ning software with deformable registration algo-
rithms (13, 14) is necessary to enable an ideal adap-
tive strategy.
Fig. 8. Coefficient of correlation of the body weight loss and
the cervical volume reduction
Fig. 9. Changes of maximum dose of spinal cord when inten-
sity-modulated radiation therapy plan was applied to the same
situation of anatomical changes derived from the present study.
Upper dose limit of spinal cord was set at 40 Gy in dose constraint
of initial radiation treatment planning of intensity modulated ra-
diation therapy.
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